Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Cash from Operations (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Cash from Operations for 5 consecutive years, with 10907000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 7.19% year-over-year to 10907000.0, compared with a TTM value of 43778000.0 through Sep 2025, up 1.06%, and an annual FY2024 reading of 44140000.0, down 34.5% over the prior year.
  • Cash from Operations was 10907000.0 for Q3 2025 at Lucid Diagnostics, down from 10500000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2182000.0 in Q3 2021 and bottomed at 13305000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 8327210.53, with a median of 9871000.0 recorded in 2024.
  • Peak annual rise in Cash from Operations hit 56.89% in 2022, while the deepest fall reached 479.99% in 2022.
  • Year by year, Cash from Operations stood at 9877000.0 in 2021, then surged by 56.89% to 4258000.0 in 2022, then tumbled by 134.36% to 9979000.0 in 2023, then grew by 1.08% to 9871000.0 in 2024, then decreased by 10.5% to 10907000.0 in 2025.
  • Business Quant data shows Cash from Operations for LUCD at 10907000.0 in Q3 2025, 10500000.0 in Q2 2025, and 12500000.0 in Q1 2025.